J. Neill

发表

Aerobic exercise improves memory and prevents cognitive deficits of relevance to schizophrenia in an animal model

M. Burgess, B. Grayson, Idil Mitsadali, 2020, Journal of psychopharmacology.

Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors

G. Reynolds, B. Grayson, J. Neill, 2009, Psychopharmacology.

Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review.

A. Markou, S. Barnes, B. Grayson, 2015, Current topics in behavioral neurosciences.

Maternal immune activation in rodent models: A systematic review of neurodevelopmental changes in gene expression and epigenetic modulation in the offspring brain

J. Glazier, R. Hager, J. Neill, 2021, Neuroscience & Biobehavioral Reviews.

Correlation of Hyperforin Content of Hypericum Perforatum(St John’s Wort) Extracts with Their Effects On Alcohol Drinking in C57Bl/6J Mice: A Preliminary Study

A. G. Smith, C. Wright, B. Grayson, 2003, Journal of psychopharmacology.

NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update

D. Cadinu, M. Harte, Nazanin Doostdar, 2017, Neuropharmacology.

(3S)‐3‐(2,3‐difluorophenyl)‐3‐methoxypyrrolidine (IRL752) —a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent

S. Hjorth, N. Waters, J. Tedroff, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.

Shikha Snigdha, Ben Grayson, Joanna C Neill, 2010, Pharmacology & therapeutics.

Isolation rearing impairs novel object recognition and attentional set shifting performance in female rats

Sl McLean, B Grayson, M Harris, 2010, Journal of psychopharmacology.

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat

B. Grayson, N. Idris, J. Neill, 2007, Behavioural Brain Research.

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat

C. Large, P. Repeto, N. Idris, 2005, Psychopharmacology.

D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.

N. Idris, J. Neill, M. Woolley, 2009, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.

Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172

Mark J. Wall, M. Wall, M. Harte, 2023, Cells.

The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia

Mark J. Wall, M. Wall, L. Iacovelli, 2022, Neuropharmacology.

PD168077, a D4 receptor agonist, reverses object recognition deficits in rats: potential role for D4 receptor mechanisms in improving cognitive dysfunction in schizophrenia

A. Young, S. Cole, B. Grayson, 2011, Journal of psychopharmacology.

Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.

Ben Grayson, John M Schaus, F. Bymaster, 2010, The international journal of neuropsychopharmacology.

Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials.

C. Correll, P. Haddad, J. Neill, 2021, The lancet. Psychiatry.

Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation

P. V. Rayudu, S. Lipton, F. Jensen, 1998, Neuroscience.

Partial agonism at the α7 nicotinic acetylcholine receptor improves attention, impulsive action and vigilance in low attentive rats

L. Adamson, J. Neill, A. Hayward, 2017, European Neuropsychopharmacology.

Attenuation of Phencyclidine-Induced Object Recognition Deficits by the Combination of Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine2A Receptor Inverse Agonist

H. Meltzer, J. Neill, M. Shahid, 2010, Journal of Pharmacology and Experimental Therapeutics.

P.3.c.003 AUT6, a novel Kv3 channel modulator, reverses cognitive and neurobiological dysfunction in a rat model of relevance to schizophrenia symptomatology

C. Large, M. Léger, M. Harte, 2015, European Neuropsychopharmacology.

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat

G. Reynolds, J. Neill, J. Neill, 2006, Journal of psychopharmacology.

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat

G. Reynolds, J. Neill, J. Neill, 2003, Journal of psychopharmacology.

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat

David R. Thomas, J. Neill, M. Woolley, 2009, Psychopharmacology.

D1-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia

N. Idris, J. Neill, M. Woolley, 2009 .

P.1.d.004 Deficits in attentional set-shifting in rats following sub-chronic phencyclidine (PCP) administration, effect of gender

K. Marshall, N. Idris, J. Neill, 2007, European Neuropsychopharmacology.